Clinical Metrics, Architecture Debt, Global Coordination, and the New Readiness Test

AI Ethics & Governance for Leaders, Boards & Trustees

By Dr. Freddie Seba

This week, one idea kept surfacing across healthcare, enterprise architecture, education, labor-market anxiety, and international AI policy conversations:

AI failures in high-trust institutions rarely begin as dramatic scandals.

They begin as ungoverned defaults inside ordinary workflows.

A setting no one reviewed.

A metric no one fully owned.

A vendor choice is absorbed as if it were an institutional judgment.

A workflow that “worked” until someone had to answer for the harm.

That is why this week’s governance lesson is simple:

Evidence is not adjacent to governance.

Evidence is governance.

If leaders cannot explain how decisions are measured, validated, updated, monitored, challenged, and owned, then they are not governing AI’s influence. They are inheriting it.

This Week’s Governance Lesson

Institutions still spend too much time asking whether the model works.

The more important question is harder:

What is the measurement, review, and accountability system around the model — and is it strong enough to govern real-world use?

Because the institutional failure mode is becoming easier to predict:

capability → adoption → local optimization → weak verification → hidden drift → contested outcomes → trust erosion

That is why the board-level question is no longer just:

Do we have AI?

It is:

Do we have an accountable evidence system around the decisions AI is shaping?

From the Field: Global AI Governance Is Becoming a Leadership Test

I was grateful to participate this week in Scaling AI Globally in San Francisco, thanks to the invitation from Cathay Innovation.

The conversation reinforced something central to my research and writing:

AI governance is no longer a local or purely institutional question. It is increasingly a cross-border leadership challenge.

I especially appreciated the participation and insights of Anne Bouverot, Special Envoy for AI to the French President, and Dr. K. Srikar Reddy, Consul General of India in San Francisco. Their presence underscored that AI governance is being shaped not only by technical capability but also by diplomacy, industrial policy, public trust, capital formation, and international coordination.

The conversation connecting the Delhi summit, the Paris AI Action Summit, and the upcoming G7 in France sharpened an important point:

Responsible AI scaling will depend on whether governance, incentives, and institutional readiness evolve alongside capability.

My thanks again to Matthieu Soulé, Paul Salvaire, and the Cathay Innovation team for convening such a timely and important discussion.

Podcast Update

Be on the lookout midweek for Episode #11 of AI Governance with Dr. Freddie Seba:

Evidence as AI Governance — Translating Clinical Decisions into Accountable Metrics

Guests:

Dr. J. Marc Overhage, MD, PhD

Advisor to Motive Medical Intelligence

Dr. Raajiv Ravi, MD, MS

VP, Product & Informatics, Motive Medical Intelligence

In this episode, I’m joined by Dr. Overhage and Dr. Ravi for a conversation that gets at a board-level issue in plain language:

If a metric is shaping decisions, who owns the metric — and who owns the harm when it is wrong?

In healthcare, AI governance fails when we debate “the model,” but do not govern the measurement system beneath it: the definitions, evidence base, benchmark logic, transparency, update process, ownership, and escalation paths that determine what gets rewarded, denied, flagged, or fast-tracked.

That is a healthcare lesson.

But it is also a wider institutional lesson.

Executive Reflection: Governance Breaks First at the Layer People Don’t See

This week’s signal is not simply that AI is improving.

It is that institutions are increasingly relying on hidden systems of judgment:

classification logic, scoring rules, workflow prompts, benchmark choices, standards mappings, retrieval structures, model routing, and post-deployment assumptions.

Those layers often look operational.

But they are where governance either becomes real or fails quietly.

That is why one of the strongest ideas this week comes from enterprise architecture:

Governance is architecture in action.

Architecture is not just diagrams. It is the operational discipline of enforcing standards. Without governance boards, review gates, and principal compliance checks, architecture debt grows faster than it can be repaid. Effective governance creates a feedback loop: each project is reviewed not only for delivery but also for alignment with long-term enterprise principles. Without governance, every local optimization becomes tomorrow’s systemic problem.

AI governance translation:

In AI, leaders cannot treat deployment as a series of isolated tool decisions. They have to govern the institution’s decision architecture itself: standards, ownership, review gates, escalation paths, and the refusal to accept vendor-set defaults as institutional judgment.

Not diagrams.

Not slogans.

Not policy theater.

Not marketing copy.

And not vendor-set defaults mistaken for institutional judgment.

What We Are Seeing: Signals

1) In healthcare, evidence systems are becoming the actual governance surface

One of the clearest lessons emerging from this week’s podcast preparation is that healthcare AI governance breaks down when organizations talk about AI capability but fail to govern the logic of measurement.

That means:

What counts as an appropriate decision,
What benchmark is being used?
how exceptions are handled,
how often the logic is updated,
And who is accountable when the metric no longer reflects reality?

AI governance translation:

If a system shapes care, reimbursement, triage, documentation, or utilization review, governance lives in the evidence and measurement systems around the tool—not in the tool alone.

2) Clinical AI oversight remains local, contextual, and supervision-dependent

A major lesson from recent healthcare AI research is that even when an AI system performs impressively in structured settings, real-world deployment still depends on supervision design, workflow fit, and local validation.

For new readers:

Google’s AMIE refers to a research AI system designed for diagnostic medical reasoning and clinical conversation.
PCPs means primary care physicians.

The practical leadership lesson is not “AI is ready.”

It is promising that results still require careful governance around implementation, monitoring, and human oversight.

Board move:

Require local validation, named clinical owners, threshold review, and post-deployment monitoring before expanding any consequential clinical AI workflow.

3) Agent capability is increasing on longer, multi-step tasks — so the control problem is changing

A recent test from the UK AI Security Institute — a U.K. public body focused on evaluating advanced AI risks — examined how frontier AI agents perform in multi-step cyberattack scenarios.

One important signal: under the same compute allowance, tested systems completed many more steps in a later generation than in earlier ones. That does not mean “a score out of 10.” It means that, under a fixed token budget, models were able to complete more steps in a multi-stage task sequence.

That matters because the governance problem shifts from single outputs to chained action capacity.

AI governance translation:

As systems improve across long-running tasks, leaders should stop governing only outputs and start governing delegated authority.

Board move:

Ask:

What can the system access?
What can it recommend?
What can it trigger?
What can it repeat without review?
What can it change before a human notices?

4) Standards are becoming the quiet infrastructure of AI governance

A strong policy signal this week comes from the growing interplay between AI standards and regulation.

For new readers:

IAPP is the International Association of Privacy Professionals, a global nonprofit professional association focused on privacy, AI governance, and digital responsibility.
OECD is the Organisation for Economic Co-operation and Development, an intergovernmental body whose AI work increasingly shapes international policy language and governance framing.

The broader lesson is that governance maturity does not mean waiting for perfect regulation. It means operationalizing review, assurance, standards alignment, and evidence-based practices now.

AI governance translation:

Mature institutions are not asking only, “What is allowed?”

They are also asking, “What is reviewable, defensible, and accountable?”

5) Public trust is becoming a governance variable, not just a communications variable

One public attitude signal leaders should not ignore is that many people do not experience AI as a separate issue. They experience it as part of a broader question about fairness, affordability, and whether institutions are prepared for disruption.

That is why public trust is no longer just a messaging issue. It is a governance issue.

If people believe AI is entering systems that already feel opaque, unequal, or unresponsive, then “trust us” will not be enough. Institutions will need visible protections, credible accountability, and governance mechanisms that people can actually understand.

AI governance translation:

Trust will not be restored by productivity claims alone.

It will require understandable safeguards, ownership, and evidence that institutions are protecting people rather than simply accelerating systems around them.

6) In education, the governance question is not just use — it is formation

A timely education signal this week warns that unstructured AI use can encourage cognitive offloading and weaken the habits that learning is supposed to build.

The deeper question is not simply whether students use AI.

It is whether institutional design preserves:

judgment,
effort,
reflection,
critical engagement,
and intellectual formation.

AI governance translation:

The real question is whether institutions are designing for passive dependence or intentional engagement.

Board move:

Move beyond detection-only strategies. Require institutions to show how AI use is being governed through:

faculty-student partnership on norms,
assignment redesign,
transparency about acceptable use,
intentional engagement with AI tools,
and explicit protection of critical thinking, authorship, and developmental learning.

7) Scale without governance discipline is still pilotitis by another name

Another signal this week, especially in healthcare and enterprise settings, is that many organizations still confuse experimentation with readiness.

The result is familiar:

too many pilots, unclear ownership, unclear integration logic, uneven follow-through, and little durable governance learning.

That is not scale.

That is an unmanaged accumulation.

AI governance translation:

An institution does not become AI-mature because it has more pilots.

It becomes mature when it can decide what to stop, what to standardize, what to monitor, and what to refuse.

The Seba Framework: The 12 Ps of Responsible AI Oversight ©

How I interpret this week’s signals through a board-ready governance lens

Purpose — mission alignment vs. convenience adoption

Problems — what decision problem is actually being solved

Profits — who benefits vs. who bears risk

People — patient, student, worker, and public impact

Planet — infrastructure, energy, and scaling implications

Process — monitoring, updates, escalation, and incident learning

Policy — rules governing the use case and its limits

Protections — red lines, vulnerable groups, and complaint pathways

Privacy — data access, retention, exposure, and secondary use

Provenance — evidence-based, benchmarks, standards, and traceability

Preparedness — leadership competence and governance cadence

Product Ownership — who owns outcomes once AI shapes action

A simple example from this week’s theme:

If a health system deploys an AI-supported metric to prioritize patient outreach, several Ps immediately come into play:

Purpose: Is the goal patient safety, cost reduction, or both?
Provenance: What evidence supports the metric?
Process: How often is it reviewed and updated?
Protections: What happens if high-risk patients are missed?
Product Ownership: Who is accountable when the system gets it wrong?

That is what it means to move from AI enthusiasm to decision-grade oversight.

Board-Ready Next Step: Require an Evidence & Accountability Sheet for Every Consequential AI Use Case

If you only do one thing this quarter, require an Evidence & Accountability Sheet for every consequential AI use case.

One page.

Named owner.

Reviewable.

Updated post-deployment.

At a minimum, it should answer seven questions:

1. What decision is being shaped?

Is the system informing triage, diagnosis, advising, drafting, routing, scoring, student support, hiring, or prioritization?

2. What evidence supports it?

What validation, benchmark, local testing, policy basis, or guideline justifies its use here?

3. What metric logic is embedded?

What exactly is being measured, classified, ranked, flagged, or recommended?

4. Who owns it?

Name the executive owner, operational owner, and escalation owner.

5. Where can it fail?

Drift, bias, over-reliance, false positives, false negatives, workflow mismatch, privacy leakage, silent nonuse, or downstream harm.

6. What human review remains required?

What cannot happen without human signoff? Who has pause authority?

7. How will we monitor it after launch?

What counts as an incident, near miss, threshold breach, or reason to retrain, restrict, or stop use?

Example:

If a health system deploys an AI tool to help prioritize patient outreach, the sheet should state:

Whether the tool is only recommending or actually routing,
what evidence supports the prioritization logic?
Who owns the metric?
how false negatives will be detected,
And who is accountable if a high-risk patient is missed?

That sheet turns “we are experimenting with AI” into:

We are governing the decisions AI is influencing.

AI Governance Book Update

I have also been discussing the forthcoming AI governance book in small, private conversations with AI practitioners, institutional leaders, and others working across healthcare, education, policy, and enterprise settings.

The early signal has been encouraging: the themes are resonating not only in the U.S., but also among audiences considering AI readiness, oversight, trust, and leadership responsibility across sectors and regions.

One thing I keep hearing is this:

The problem is not a lack of AI conversation.

It is a lack of decision-grade governance conversation.

That feedback is helping sharpen the direction of the book:

less abstract debate about AI tools, more clarity about responsibility, escalation, fiduciary oversight, and institutional accountability.

About the Author

Freddie Seba writes and speaks on AI ethics and AI governance for leaders, boards, and trustees across higher education, healthcare, and financial services.

He is a researcher-practitioner with experience across Silicon Valley startups, global firms, and higher education. He holds an MBA from Yale, an MA in International Policy Studies from Stanford, and an EdD in Organization and Leadership from the University of San Francisco.

He writes AI Ethics & Governance for Leaders, Boards & Trustees and hosts AI Governance with Dr. Freddie Seba, translating emerging signals into board-ready oversight: decision rights, risk tiering, vendor accountability, monitoring, and incident preparedness.

Gratitude

Grateful to the communities and conversations that keep this work grounded:

@University of San Francisco • @AMIA Informatics • @Stanford HAI • @Coalition for Health AI

And grateful again to the hosts and participants at Cathay Innovation’s San Francisco gathering for sharpening the global governance lens this week.

Transparency + Disclaimer

Educational content only. This newsletter does not constitute legal, medical, clinical, insurance, financial, or professional advice.

Drafted and refined with AI-assisted tools for synthesis and clarity. Final editorial control and responsibility remain with the author.

#AIGovernance #ResponsibleAI #BoardOversight #HealthcareAI #ClinicalInformatics #AILeadership #DigitalHealth #TrustInfrastructure #RiskManagement #HigherEd #GlobalAI #AIEthics

Sources for Episode #11 guests

This week’s field signal/event context

NVIDIA GTC session catalog

https://www.nvidia.com/gtc/session-catalog/?formats=In-Person&keyThemes=Claws%26LongRunningAgents&startTime=8&endTime=19&ncid=so-nvsh-644983&es_id=a6ce31e983

Selected governance/research signals from this week

Technical debt vs. architecture debt

https://thenewstack.io/technical-debt-vs-architecture-debt-dont-confuse-them

UK AI Security Institute: multi-step cyberattack scenarios

https://www.aisi.gov.uk/blog/how-do-frontier-ai-agents-perform-in-multi-step-cyber-attack-scenarios?mkt_tok=MTM4LUVaTS0wNDIAAAGgoUvD5fk4Ur4-0HYGRpLkkvvj4lLS_xQk4iv18KNgqDqCVGGtrkfRVHeQFtU67pfTPRSqK1gym5aka5yj0MShrfqevumP1neei3uJhsIUi6YzZA

IAPP: AI standards and regulation

https://iapp.org/news/a/the-interplay-between-AI-standards-regulations?mkt_tok=MTM4LUVaTS0wNDIAAAGgoUvD5YinwMLh3jUKxHQxPZdSkm0kmw9I4Xd845-bfhczBeIRPlt5iaIjAUdoQhsDGcaILU_Hh3oXIwSgRYI74Fs-KVRWanYI37efnT_ahD_a4g

Colorado AI policy workgroup